APP and Cognitive impairment: Previous studies have pointed out various types of AD pathophysiology such as cerebrospinal fluid levels of amyloid-β (Aβ) [32] and other clinical presentations such as cognitive impairments with executive dysfunction and disorientation, language impairment, and memory loss in patients with mutations of either APP, PSEN1, or PSEN2 genes.